Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
Read our latest update

US Bioservices now dispenses BIKTARVY

February 9, 2018

The U.S. Food and Drug Administration has approved BIKTARVY (bictegravir, emtricitabine, tenofovir alafenamide) for the treatment of adults with HIV-1 infection.